| 000 | 01830 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513121722.0 | ||
| 264 | 0 | _c19970815 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0342-4642 | ||
| 024 | 7 |
_a10.1007/s001340050366 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSinclair, D G | |
| 245 | 0 | 0 |
_aGastrointestinal permeability following cardiopulmonary bypass: a randomised study comparing the effects of dopamine and dopexamine. _h[electronic resource] |
| 260 |
_bIntensive care medicine _cMay 1997 |
||
| 300 |
_a510-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAPACHE |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aBiological Transport _xdrug effects |
| 650 | 0 | 4 |
_aCarbohydrates _xpharmacokinetics |
| 650 | 0 | 4 |
_aCardiopulmonary Bypass _xadverse effects |
| 650 | 0 | 4 |
_aDopamine _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aGlucose _xpharmacokinetics |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
| 650 | 0 | 4 |
_aLactulose _xpharmacokinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPermeability _xdrug effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRhamnose _xpharmacokinetics |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aXylose _xpharmacokinetics |
| 700 | 1 | _aHouldsworth, P E | |
| 700 | 1 | _aKeogh, B | |
| 700 | 1 | _aPepper, J | |
| 700 | 1 | _aEvans, T W | |
| 773 | 0 |
_tIntensive care medicine _gvol. 23 _gno. 5 _gp. 510-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s001340050366 _zAvailable from publisher's website |
| 999 |
_c9182034 _d9182034 |
||